Sell Ranbaxy Laboratories: Mohoni

Published on Tue, Jan 15, 2008 at 14:58 |  Source : Moneycontrol.com

Updated at Tue, Jan 15, 2008 at 16:21  

54182 Investors following Ranbaxy Labs. Share this News with them.
0
0
Share on Tumblr
Deepak Mohoni, Technical Analyst, .

Excerpts from Midcap Radar on CNBC-TV18 Watch the full show »

RELATED NEWS

ALSO READ

Technical Analyst, Deepak Mohoni is of the view that one can sell Ranbaxy Laboratories .

Mohoni told CNBC-TV18, "Ranbaxy Laboratories is a sell and not really a buy because the stock has never really been able to catch up with its 2004 peak. It is slowly eroding throughout the entire bull market. It looks like it was making a bit of a move in the last few months but now it looks like it has sort of top towered for the year. It's looking fairly weak. On market decline it's a good short sell and for the portfolio the stock shouldn't really be in there."

Disclosure: Analyst doesn't hold the above stock.

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com